Specialty drug sales, record-breaking M&A paired with tax synergies, and global expansion helped to bring a new face into this year’s Pharma 50 top 10, and substantially boosted the rankings of several others.
David Hole
Advertisement
Articles by David Hole
Advertisement
Latest Updated Articles
Taking Flight: Pharm Exec's Top 50 Pharma Companies 2015Published: July 14th 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Novo Nordisk's Shares Fall After Board Shake-Up
2
Roundup: Pharma Industry Raises Funding Aimed at Advancing the Development and Testing of Rare Disease Treatments
3
Moderna Ceases Development of mRNA-1647 After Failing to Reach Primary Goal in Clinical Trial
4
Novo Nordisk Stock Reacts to Recent Board Changes
5
